Plain-English translation of NCT06860490 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether combining two medications called and with an additional treatment called hepatic arterial infusion chemotherapy (HAIC) works better than using the two medications alone for advanced liver cancer. The HAIC treatment delivers chemotherapy directly into the blood vessels that feed the liver tumor, while the other two medications help the body's immune system fight cancer. The study will compare how well these approaches work and how safe they are.
Advanced liver cancer is a serious disease, and current treatments don't work for everyone. Researchers believe that combining this medication with a targeted infusion therapy might help more patients by attacking the cancer in multiple ways at once.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the two medications alone or the two medications combined with the hepatic arterial infusion therapy. You will have regular clinic visits for blood tests, imaging scans, and checkups to see how you're responding to treatment and to monitor for any side effects. The study involves 164 patients across multiple medical centers, and you'll be followed closely throughout the treatment period and beyond.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Phase
Testing effectiveness
Sponsor
Fudan University
Enrollment target
~164 participants
Started
March 2025
Primary completion
March 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Peng Wang, MD
Fudan University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.